Online Inquiry
Erdafitinib (JNJ-42756493)
SPC-00813
CAS No. 1346242-81-6
| Size | Price |
| 5 mg | Online Inquiry |
| Bulk Size | Online Inquiry |
FGFR inhibitor ; c-RET inhibitor ; CSF-1R inhibitor ; PDGFR inhibitor ; VEGFR inhibitor ; Apoptosis related activator ; c-Kit inhibitor
| Description |
|---|
| Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Erdafitinib also binds to RET, CSF-1R, PDGFR-α/PDGFR-β, FLT4, KIT and VEGFR-2 and induces cellular apoptosis. |
| Product Details | |
|---|---|
| CAS No. | CAS No. 1346242-81-6 |
| Description | Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Erdafitinib also binds to RET, CSF-1R, PDGFR-α/PDGFR-β, FLT4, KIT and VEGFR-2 and induces cellular apoptosis. |
| Formula | C25H30N6O2 |
| Molecular Weight | 446.54 |
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
| Synonyms | N/A |
| SMILES | CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC |
| Usage | |
|---|---|
| Storage | 3 years -20°C powder 2 years -80°C in solvent |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.